References
- Nakamura N.; Obayashi H.; Fujii M.; Fukui M.; Yoshimori K.; Ogata M. Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Radic. Biol. Med. 2000, 29 (1), 17–25. [PUBMED], [INFOTRIEVE], [CSA]
- Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Inter., Suppl. 2000, 77, S3–S12. [CROSSREF], [CSA]
- Opara E C.; Abdel-Rahman E.; Soliman S.; Kamel W A.; Souka S.; Lowe J E. Depletion oftotal antioxidant capacity in type 2 diabetes. Metabolism 1999, 48, 1414–1417. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koya D.; King G L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47, 859–866. [PUBMED], [INFOTRIEVE]
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329, 977. [CROSSREF]
- Remuzzi A.; Fassi A.; Sangali F.; Malanchini B.; Mohamed E I.; Bertani T.; Remuzzi G. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism. Exp. Nephrol. 1998, 6, 28–38. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ha H.; Kim K H. The amelioration of diabetic microalbuminuria and lipid peroxidation by captopril. Yonsei Med. J. 1992, 33, 217–223. [PUBMED], [INFOTRIEVE]
- de Cavanagh E M.; Inserra F.; Toblli J.; Stella I.; Fraga C G.; Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001, 38, 1130–1136. [PUBMED], [INFOTRIEVE]
- Chan W.; Krieg R J., Jr.; Norkus E P.; Chan J C.M. α-Tocopherol reduces proteinuria, oxidative stress, and expression of Transforming Growth Factor β in IgA nephropathy in the rat. Mol. Genet. Metab. 1998, 63, 224–229. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koya D.; Lee I K.; Ishii H.; Kanoh H.; King G L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J. Am. Soc. Nephrol. 1997, 8, 426–435. [PUBMED], [INFOTRIEVE], [CSA]
- Trachtman H. Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc. Res. 1994, 47, 232–239. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mekinova D.; Chorvathova V.; Volkouova K.; Staruchova M.; Grancicova E.; Kivanova J.; Ondreicka R. Effect of intake of exogenous vitamins C, E and beta-carotene on antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995, 39, 257–261. [PUBMED], [INFOTRIEVE], [CSA]
- Fryer M J. Vitamin E as a protective antioxidant in progressive renal failure. Nephrology 2000, 5, 1–7. [CROSSREF]
- Ihara Y.; Yamada Y.; Toyokuni S.; Miujawaki K.; Ban N.; Adachi T. Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 2000, 473, 24–26. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Horvath B.; Marton Z.; Halmosi R.; Alexy T.; Szapary L.; Vekasi J. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clin. Neuropharmacol. 2002, 25 (1), 37–42. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bhat V B.; Madyastha K M. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem. Biophys. Res. Commun. 2001, 288 (5), 1212–1217. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freitas J P.; Filipe P.; Guerra Rodrigo F. Potential antioxidative effects of pentoxifylline. C.R. Seances. Soc. Biol. Fil. 1995, 189 (3), 401–405. [PUBMED], [INFOTRIEVE], [CSA]
- Freitas J P.; Filipe P M. Pentoxifylline: a hydroxyl radical scavenger. Biol. Trace Elem. Res. 1995, 47 (1–3), 307–311. [PUBMED], [INFOTRIEVE], [CSA]
- Dávila-Esqueda M E.; Martínez F. Pentoxifylline protects the streptozotocin induced oxidative damage to renal tissue in rats. Experimental Diabetes Research 2004, 5, 1–17. [CSA]
- Navarro J F.; Mora C. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy. Diabetes Care 1999, 22, 1006–1008. [PUBMED], [INFOTRIEVE], [CSA]
- Guerrero-Romero F.; Rodríguez-Moran M.; Paniagua-Sierra J R.; Garcia-Bulnes G.; Salas-Ramírez M.; Amato D. Pentoxifylline reduces proteinuria in insulin-dependent and non-insulin-dependent diabetic patients. Clin. Nephrol. 1995, 43, 116–121. [PUBMED], [INFOTRIEVE], [CSA]
- Tripathi K.; Prakash J.; Appaiha D.; Srivastava P K. Pentoxifylline in management of proteinuria in diabetic nephropathy. Nephron 1993, 64 (4), 641–642. [PUBMED], [INFOTRIEVE]
- Harmankaga O.; Seber S.; Yuksel A.; Yilmaz M.; Unsal A. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients. Ren. Fail. 2003, 25 (3), 465–470. [CROSSREF]
- Miller N J.; Rice-Evans C.; Davies M J.; Gopinathan U.; Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 1993, 84, 407–412. [PUBMED], [INFOTRIEVE]
- Cooper J D.H.; Thadwal R.; Cooper M J. Determination of vitamin E in human plasma by high-performance liquid chromatography. J. Chromatogr., B 1997, 690, 355–358.
- Julianto T.; Yuen K H.; Noor A M. Simple high-performance liquid chromatography. J. Chromatogr., B. 1999, 732, 227–231.
- Koya D.; Hayashi K.; Kitada M.; Kashiwagi A.; Kikkawa R.; Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 2003, 14, S250–S253. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jachec W.; Tomasik A.; Tarnawski R.; Chwalinska R. Evidence of oxidative stress in the renal cortex of diabetic rats: favorable effect of vitamin E. Scand. J. Clin. Lab. Invest. 2002, 62, 81–88. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Torres M D.; Canal J R.; Pérez C. Oxidative stressin normal and diabetic rats. Physiol. Res. 1999, 48, 203–208. [PUBMED], [INFOTRIEVE], [CSA]
- Fryer M J. Vitamin E as a protective antioxidant in progressive renal failure. Nephrology 2000, 5, 1–7. [CROSSREF]
- Görgün F M.; Gümüstas M K. Vitamin E supplementation in streptozotocin-treated rats alters cerebelar and plasma nitric oxide metabolism. J. Toxicol. Environ. Health, Part A 2002, 65, 631–637. [CROSSREF], [CSA]
- Kim S S.; Gallaher D D.; Csallany A S. Vitamin E and Probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocin-induced diabetic rats. Lipids 2000, 35 (11), 1225–1237. [PUBMED], [INFOTRIEVE], [CSA]
- Wagner B A.; Buettner G R.; Burns C P. Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells. Arch. Biochem. Biophys. 1996, 334 (2), 261–267. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Van den Braden C.; Deman A.; Ceyssens B.; Pauwels M.; Empsen C.; Verbeelen D. Vitamin E protects renal antioxidant enzymes and attenuates glomeruloesclerosis in Adriamycin-treated rats. Nephron 2002, 91 (1), 129–133. [CROSSREF], [CSA]
- Lee H B.; Yu M R.; Yang Y.; Jiang Z.; Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 2003, 14 (8), S241–S245. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nishikawa T.; Edelstein D.; Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int.periodicpubfield>2000, 58, S26–S30. [CROSSREF]